Compare Definium Therapeutics Inc. Common Shares (DFTX) vs SPDR Kensho Final Frontiers ETF (ROKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs SPDR Kensho Final Frontiers ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while SPDR Kensho Final Frontiers ETF trades at $102.84 (market cap $170.14M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 27× SPDR Kensho Final Frontiers ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, SPDR Kensho Final Frontiers ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and SPDR Kensho Final Frontiers ETF for 8 Days on average.
| DFTX | ROKT | |
|---|---|---|
Market Cap | $4.59B | $170.14M |
Volume | 2,103,937 | 12,298 |
Sector | Health | Sector/Thematic |
52-Week High | $48.45 | $136.68 |
52-Week Low | $10.68 | $72.93 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $3.55B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →
